Related Experiment Videos
Solitary bone plasmacytoma in a young patient
K Panteli1, St Tsiara, K L Bourantas
1Dept of Internal Medicine, University of Ioannina Medical School, Greece.
Journal of Experimental & Clinical Cancer Research : CR
|June 20, 2002
Abstract:
Plasma cell disorder, a disease of the elderly, is extremely rare in those below 30 years of age. A young 18 year old patient with solitary plasmacytoma is described in this case report.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Malignancies in beta-thalassemia patients: a single-center experience and a concise review of the literature.
International journal of laboratory hematology·2008
Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2007
Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim support.
Clinical and laboratory haematology·2006
Beneficial effect of rituximab in combination with oral cyclophosphamide in primary chronic cold agglutinin disease.
International journal of hematology·2005
Clinical correlation of bone marrow microvessel density in essential thrombocythemia.
Acta haematologica·2005
Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.
Journal of experimental & clinical cancer research : CR·2026
Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance.
Journal of experimental & clinical cancer research : CR·2026
Tailored FcγR blockade enhances immune checkpoint therapy and overcomes resistance.
Journal of experimental & clinical cancer research : CR·2026
Transcriptional evidence of neuroendocrine cell plasticity beyond histological boundaries in lung neuroendocrine neoplasms: an in-silico analysis suggesting a progression model.
Journal of experimental & clinical cancer research : CR·2026
Soulangianolide A targets FAM120A to disrupt SREBP1-driven lipid metabolic reprogramming and suppress clear cell renal cell carcinoma.
Journal of experimental & clinical cancer research : CR·2026
TWIST1 bridges p53 and MDM2 and impairs the efficacy of MDM2 inhibitors.
Journal of experimental & clinical cancer research : CR·2026
Beyond the Rash: Simultaneous Bilateral Facial Nerve Palsy Following Childhood Varicella Infection.
Clinical case reports·2026